| 251 |
9788435 | Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs. | 1998 Oct 15 |
1 |
| 252 |
9343394 | Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. | 1997 Nov |
3 |
| 253 |
9494534 | Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. | 1997 Nov-Dec |
1 |
| 254 |
14646555 | Serum withdrawal and etoposide induce apoptosis in human lung carcinoma cell line A549 via distinct pathways. | 1997 |
1 |
| 255 |
8620501 | Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. | 1996 Apr 15 |
3 |
| 256 |
8673929 | Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. | 1996 Jul |
1 |
| 257 |
8706243 | Drug-resistant breast cancer cells frequently retain expression of a functional wild-type p53 protein. | 1996 Jul |
1 |
| 258 |
8875976 | p53 N-terminus-targeted protein kinase activity is stimulated in response to wild type p53 and DNA damage. | 1996 Oct 3 |
1 |
| 259 |
8950479 | Apoptosis and cancer chemotherapy. | 1996 Oct |
1 |
| 260 |
9816212 | Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2. | 1996 Apr |
1 |
| 261 |
7750085 | Apoptosis and nuclear levels of p53 protein and proliferating cell nuclear antigen in human hepatoma cells cultured with tumor promoters. | 1995 May 4 |
1 |
| 262 |
8562479 | Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress. | 1995 Nov |
1 |
| 263 |
9815936 | Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide. | 1995 Nov |
1 |
| 264 |
7923116 | The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. | 1994 Oct 1 |
1 |
| 265 |
7954409 | p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. | 1994 Nov 15 |
6 |
| 266 |
7970699 | Mechanisms of regulation of WAF1/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. | 1994 Dec |
4 |
| 267 |
8485705 | Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. | 1993 May 15 |
1 |